Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
SciClone Pharmaceuticals is a biopharmaceutical company engaged in the development of therapeutics to treat life-threatening diseases. SciClone is currently evaluating its lead product ZADAXIN in several late stage clinical trials, including two phase 3 hepatitis C clinical trials in the U.S., a completed phase 3 hepatitis B clinical trial in Japan, a phase 2 malignant melanoma clinical trial in Europe, two phase 2 liver cancer pilot studies in the U.S., and a hepatitis C triple therapy pilot clinical trial in Mexico. The Company’s other principal drug development candidate is SCV-07, a potentially orally available therapeutic to treat viral and infectious diseases. ( www.sciclone.com )
SciClone Pharmaceuticals , Inc.
901 Mariner’s Island Blvd. Suite 205
San Mateo, California 94404
USA
Tel: (650) 358-3456
Fax: (650) 358-3469